CAS OpenIR

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysis 期刊论文
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 卷号: 51, 期号: 10, 页码: 2513-2521
作者:  Yelei Guo;  Beilei Xu;  ZhiqiangWu;  JianBo;  ChuanTong;  Deyun Chen;  JinWang;  HaoyiWang;  YaoWang;  Weidong Han
浏览  |  Adobe PDF(2464Kb)  |  收藏  |  浏览/下载:135/67  |  提交时间:2023/04/17
PHASE I STUDY OF CAR-T CELLS WITH PD-1 AND TCR DISRUPTION IN MESOTHELIN-POSITIVE SOLID TUMORS 期刊论文
Cellular & Molecular Immunology, 2021, 卷号: 18, 期号: 9, 页码: 2188-2198
作者:  Wang Zhenguang;  Li Na;  Feng Kaichao;  Chen Meixia;  Zhang Yan;  Liu Yang;  Yang Qingming;  Nie Jing;  Tang Na;  Zhang Xingying;  Cheng Chen;  Shen Lianjun;  He Jiaping;  Ye Xun;  Cao Wei;  Wang Haoyi;  Han Weidong
浏览  |  Adobe PDF(2197Kb)  |  收藏  |  浏览/下载:179/86  |  提交时间:2023/04/17
Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway 期刊论文
ONCOIMMUNOLOGY, 2020, 卷号: 9, 期号: 1
作者:  Li Na;  Tang N(唐娜);  Cheng Chen;  Hu Tao;  Wei Xiaofei;  Han Weidong;  Wang HY(王皓毅)
浏览  |  Adobe PDF(4365Kb)  |  收藏  |  浏览/下载:315/164  |  提交时间:2021/10/26
Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2020, 卷号: 38, 期号: 15
作者:  Wang Zhenguang;  Chen Meixia;  Zhang Yan;  Liu Yang;  Yang Qingming;  Nie Jing;  Shen Lianjun;  Jiang Pengfei;  He Jiaping;  Ye Xun;  Cao Wei;  Wang HY(王皓毅);  Han Weidong
浏览  |  Adobe PDF(454Kb)  |  收藏  |  浏览/下载:322/133  |  提交时间:2021/10/26
TGF-beta inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors 期刊论文
JCI INSIGHT, 2020, 卷号: 5, 期号: 4
作者:  Tang N(唐娜);  Cheng Chen;  Zhang Xingying;  Qiao Miaomiao;  Li Na;  Mu Wei;  Wei Xiao-Fei;  Han Weidong;  Wang HY(王皓毅)
浏览  |  Adobe PDF(11792Kb)  |  收藏  |  浏览/下载:212/83  |  提交时间:2021/10/26